Potential value of color vision aids for varying degrees of color vision deficiency.


Journal

Optics express
ISSN: 1094-4087
Titre abrégé: Opt Express
Pays: United States
ID NLM: 101137103

Informations de publication

Date de publication:
14 Mar 2022
Historique:
entrez: 18 3 2022
pubmed: 19 3 2022
medline: 22 3 2022
Statut: ppublish

Résumé

Red-green color vision deficiency (CVD) is the most common single locus genetic disorder in humans, affecting approximately 8% of males and 0.4% of females [G. H. M. Waaler, Acta Ophthalmol.5, 309 (2009)10.1111/j.1755-3768.1927.tb01016.x]; however, only about 1/4 of CVD individuals are dichromats who rely on only two cone types for color vision. The remaining 3/4 are anomalous trichromats whose CVD is milder, being based on three cone types, and who still perform remarkably well on many color-based tasks. To illustrate this, we have developed an algorithm that computes the relative loss of color discrimination in red-green CVD individuals with varying degrees of deficiency and accurately simulates their color experience for color normal observers. The resulting simulation illustrates the large gap in color discrimination between dichromats and even the most severe anomalous trichromats, showing that, relative to dichromats, the majority of anomalous trichromats can function without aids for color vision deficiency.

Identifiants

pubmed: 35299329
pii: 470018
doi: 10.1364/OE.451331
pmc: PMC8970702
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8857-8875

Subventions

Organisme : NEI NIH HHS
ID : P30 EY001730
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY027859
Pays : United States

Références

J Opt Soc Am A Opt Image Sci Vis. 2014 Apr 1;31(4):A195-207
pubmed: 24695170
J Opt Soc Am A Opt Image Sci Vis. 2018 Apr 1;35(4):B278-B286
pubmed: 29603944
Transl Vis Sci Technol. 2016 Sep 06;5(5):2
pubmed: 27622081
J Opt Soc Am A Opt Image Sci Vis. 2008 Nov;25(11):2817-25
pubmed: 18978861
Ophthalmic Physiol Opt. 2010 Sep;30(5):602-10
pubmed: 20883345
IEEE Trans Vis Comput Graph. 2009 Nov-Dec;15(6):1291-8
pubmed: 19834201
Vis Neurosci. 2004 May-Jun;21(3):431-6
pubmed: 15518225
J Opt Soc Am A Opt Image Sci Vis. 1997 Oct;14(10):2647-55
pubmed: 9316278
Vision Res. 1994 May;34(10):1279-99
pubmed: 8023437
Arch Ophthalmol. 2000 May;118(5):691-700
pubmed: 10815162
J Vis. 2002;2(8):531-42
pubmed: 12678637
Vis Neurosci. 2004 May-Jun;21(3):477-82
pubmed: 15518233
J Vis. 2014 Nov 20;14(13):19
pubmed: 25413625
Am J Ophthalmol. 1966 Jul;62(1):27-37
pubmed: 5936523
Arch Ophthalmol. 1993 May;111(5):639-41
pubmed: 8489445
Vision Res. 2011 Apr 13;51(7):633-51
pubmed: 21167193
Nature. 1995 Jul 13;376(6536):127-8
pubmed: 7603561
Science. 1996 Nov 1;274(5288):801-4
pubmed: 8864125
J Opt Soc Am A Opt Image Sci Vis. 1993 Aug;10(8):1773-84
pubmed: 8350160

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH